Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-12-11, Stock:JNJ, The news for the past five days is as follows:
2019-12-04: NEWS1: Johnson & Johnson (JNJ) Outpaces Stock Market Gains: What You Should Know.NEWS2: Wall Street rebounds on trade hopes.NEWS3: Dow Jones Today: A Trade Redemption Story.NEWS4: US STOCKS-Wall Street bounces back on renewed trade optimism.NEWS5: JNJ Stock Rallies As New Testing Rules Out Asbestos In Baby Powder.NEWS6: Stock Market Gets Shot Of Adrenaline From Trump Trade Remarks; Dow's Apple, Goldman Rally.NEWS7: US STOCKS-Wall Street rebounds on renewed U.S.-China trade optimism.NEWS8: Johnson & Johnson Says the Government Was Wrong About Asbestos In Baby Powder — and Its Stock Is Rising.NEWS9: Stocks Bounce Broadly; J&J Breaks Out, But Is The Chart In Trouble?.NEWS10: US STOCKS-Renewed hopes of trade deal push Wall Street higher.NEWS11: Dow Jones Jumps 200 Points As China News Fuels Stock Market Rally.NEWS12: US STOCKS-Wall Street bounces on trade deal hopes.NEWS13: New Tests Find No Asbestos In J&J Baby Powder — Is JNJ Stock A Safe Buy?.NEWS14: US STOCKS-Wall St rises on renewed hopes of trade deal.NEWS15: AstraZeneca Sells Schizophrenia Drug Rights in US and Canada.NEWS16: Dow's nearly 175-point jump highlighted by gains in shares of Dow Inc., Johnson & Johnson.NEWS17: US STOCKS-Wall St set for higher open as report rekindles hopes of trade deal.NEWS18: J&J's (JNJ) New Tests Reveal No Asbestos in Baby Powders.NEWS19: Johnson & Johnson Says Government Is Wrong About Asbestos in Its Baby Powder.NEWS20: UPDATE 1-J&J says new tests show no asbestos in Johnson's Baby Powder.
2019-12-05: NEWS1: /C O R R E C T I O N -- Johnson & Johnson/.NEWS2: Dow Jones Today: Trade Influenced Stocks More Than Impeachment News.NEWS3: 3M, Cisco share losses lead Dow's 75-point fall.NEWS4: J&J Stock Witnesses Volatility in '19: What to Expect in 2020.NEWS5: Abbott Is One Of The Biggest Medical Stocks — Should You Buy ABT Stock Now?.NEWS6: UPDATE 2-Half a million Ebola vaccine doses to be stockpiled for emergency use.
2019-12-06: NEWS1: 4 Health Care Stocks Gurus Broadly Own.NEWS2: Here's why Oregon rejected Johnson & Johnson's pelvic mesh settlement offer.NEWS3: Pharma Stock Roundup: FDA Updates for RHHBY, AZN, MRK, No Asbestos in Talc Says JNJ.NEWS4: Glaxo Files NDA for Fostemsavir for Heavily Pre-Treated HIV.
2019-12-09: NEWS1: J&J CEO Gorsky spurns U.S. congressional hearing on carcinogens in talc products.NEWS2: J&J CEO spurns U.S. congressional hearing on carcinogens in talc products.NEWS3: Johnson & Johnson Emerging Out Of A Dark Place.NEWS4: Amgen Gets FDA Approval for J&J/Merck's Remicade Biosimilar.NEWS5: J&J Presents Data on CAR-T Therapy Drug and Imbruvica at ASH.NEWS6: Bluebird Bio Stock Is Rising on Promising Cancer-Drug Data.
2019-12-10: NEWS1: Johnson & Johnson (JNJ) Dips More Than Broader Markets: What You Should Know.NEWS2: Johnson & Johnson to Host Investor Conference Call on Fourth-Quarter Results.NEWS3: Drug manufacturers have spent a record $342 billion on M&A in 2019.NEWS4: UPDATE 1-J&J CEO spurns U.S. congressional hearing on carcinogens in talc products.

Answer: Rise